Ignite Creation Date:
2024-05-06 @ 3:49 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02385279
Status:
COMPLETED
Last Update Posted:
2023-05-08
First Post:
2015-02-17
Brief Title:
Study Comparing the MiStent SES Versus the XIENCE EES Stent
Sponsor:
ECRI bv
Organization:
ECRI bv
Study Overview
Official Title:
Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System MiStent SES for Revascularization of Coronary Arteries
Status:
COMPLETED
Status Verified Date:
2022-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DESSOLVE III
Brief Summary:
The primary objective of this study is to compare the performance of MISTENT to that of XIENCE in an all-comers patient population with symptomatic ischemic heart disease The patients will be followed through 3 years for major clinical events
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None